Drugs & Targets FDA grants priority review to Merck’s sBLA for Keytruda monotherapy in SCLC February 22, 2019Vol.45 No.08
Drugs & Targets FDA publishes revised draft guidance for investigational tobacco products February 22, 2019Vol.45 No.08
Clinical Roundup Guidelines recommend genetic testing for all people with breast cancer February 22, 2019Vol.45 No.08
Clinical Roundup Keytruda + Inlyta reduced risk of death by nearly half compared to sunitinib in RCC February 22, 2019Vol.45 No.08
Clinical Roundup OS and PFS for Keytruda in hepatocellular carcinoma did not meet statistical significance February 22, 2019Vol.45 No.08
Clinical Roundup Merck expands immuno-oncology program with three phase III trials in prostate cancer February 22, 2019Vol.45 No.08
Clinical Roundup Opdivo + Yervoy shows response in pre-treated patients with prostate cancer February 22, 2019Vol.45 No.08
Clinical Roundup Janssen announces preliminary results from phase II GALAHAD in prostate cancer February 22, 2019Vol.45 No.08
Clinical Roundup Roswell Park researchers identify protein that contributes to racial disparities in prostate cancer February 22, 2019Vol.45 No.08
